ANGELIQUE TCHOUNKOVSKY: Open Payments
NPI 1760712483 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,406 in 63 payments from 25 companies in 2025. Trend: 2023 $1,126 · 2024 $1,655 · 2025 $1,406
Food & beverage: $1,406
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 9 | $220 |
| Novo Nordisk Inc | 10 | $170 |
| Amgen Inc. | 5 | $167 |
| Lilly USA, LLC | 6 | $117 |
| Corcept Therapeutics | 4 | $99 |
| Madrigal Pharmaceuticals | 3 | $76 |
| Sequel Med Tech, LLC | 2 | $73 |
| Xeris Pharmaceuticals, Inc. | 3 | $67 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| SANOFI-AVENTIS U.S. LLC | 2 | $51 |
Products named: FREESTYLE LIBRE 3, EVENITY, Ozempic, MOUNJARO, Korlym, REZDIFFRA, TWIIST, GVOKE HYPOPEN.
Industry payments across TX — which companies pay providers there.
